Aspira Women's Health Inc. (AWHL) shareholders
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Ownership
Institutional holdings as of Dec 31, 2025, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Schuler Jack W Joint filing with Jack W. Schuler Living Trust (8.60%) | 4,052,587 | 8.70% | 13D (active) amendment | Jun 5, 2026 |
Top institutional holders
13F holdings as of Dec 31, 2025
| Holder | Shares | % of AWHL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Motiv8 Investments LLC | 33 | 0.00% | $0 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q4 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 1 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 0 / 0 | 1 / 1 | 0M | 0M |
| Q2 2025 | 2 | 0M | 0.2% | 0 / 1 | 1 / 23 | 0M | 1M |
| Q1 2025 | 25 | 1M | 1.9% | 3 / 9 | 5 / 4 | 0M | 1M |
| Q4 2024 | 26 | 1M | 3.1% | 4 / 4 | 9 / 3 | 0M | 1M |
| Q3 2024 | 25 | 2M | 5.1% | 5 / 7 | 6 / 5 | 1M | 0M |
| Q2 2024 | 26 | 1M | 3.0% | 5 / 9 | 5 / 2 | 0M | 1M |
| Q1 2024 | 23 | 2M | 4.1% | 2 / 10 | 4 / 3 | 1M | 0M |
| Q4 2023 | 24 | 1M | 1.5% | 5 / 10 | 3 / 5 | 0M | 0M |
| Q3 2023 | 24 | 1M | 1.4% | 4 / 9 | 7 / 2 | 0M | 0M |
| Q2 2023 | 22 | 1M | 1.1% | 22 / 0 | 0 / 0 | 1M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John Strahley | Chief Financial Officer | – | – | Oct 2, 2026 |
| Brian Hungerford | Chief Financial Officer | – | – | Sep 4, 2025 |
| Michael William Buhle | Chief Executive Officer | – | – | May 27, 2025 |
| James C. Crawford | Vice President of Finance | – | – | Mar 24, 2025 |
| Sandra Milligan | Interim CEO | 13,644 | 0.03% | Jan 29, 2025 |
| Jeffrey k. cohen | Director | 457,028 | 0.98% | May 29, 2026 |
| John D. Fraser | Director | 854,162 | 1.83% | May 29, 2026 |
| Cynthia D. Hundorfean | Director | – | – | Dec 4, 2025 |
| Ellen Beausang | Director | 6,458 | 0.01% | Dec 3, 2025 |
| Winfred Parnell | Director | 71,209 | 0.15% | Dec 3, 2025 |
| Jane Pine Wood | Director | – | – | Dec 3, 2025 |
| Ellen O'Connor Vos | Director | 73,989 | 0.16% | Jun 6, 2025 |
| John Phillip Ragard | Director | 134,734 | 0.29% | Jun 6, 2025 |
| Stefanie L. Cavanaugh | Director | 78,726 | 0.17% | Jun 5, 2025 |
| Jannie Prestridge Herchuk | Director | 82,502 | 0.18% | Jun 5, 2025 |
| Celeste Rachelle Fralick | Director | 55,665 | 0.12% | Apr 1, 2025 |
| Jack W. Schuler | 10% owner | 4,052,587 | 8.69% | Jun 9, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jack W. Schuler 10% owner | Jun 5, 2026 | Buy | +222,222 | $0.45 | $100.00K | 4,046,051 |
| John D. Fraser Director | Sep 17, 2025 | Buy | +16,389 | $0.45 | $7.38K | 566,393 |
| Jeffrey k. cohen Director | Sep 17, 2025 | Other | +11,112 | $0.45 | $5.00K | 386,018 |
| Jeffrey k. cohen Director | Sep 17, 2025 | Buy | +55,556 | $0.45 | $25.00K | 374,906 |
| Jack W. Schuler 10% owner | Sep 17, 2025 | Buy | +1,111,111 | $0.45 | $500.00K | 3,823,829 |
| Jeffrey k. cohen Director | Sep 17, 2025 | Buy | +55,556 | $0.45 | $25.00K | 375,697 |
| John D. Fraser Director | Sep 17, 2025 | Buy | +16,389 | $0.45 | $7.38K | 566,393 |
| Ellen O'Connor Vos Director | Jun 4, 2025 | Option exercise | +5,312 | – | – | 73,989 |
| John Phillip Ragard Director | Jun 4, 2025 | Option exercise | +4,844 | – | – | 134,734 |
| Winfred Parnell Director | Jun 4, 2025 | Option exercise | +5,156 | – | – | 71,209 |
| Stefanie L. Cavanaugh Director | Jun 4, 2025 | Option exercise | +5,937 | – | – | 78,726 |
| Jannie Prestridge Herchuk Director | Jun 4, 2025 | Option exercise | +8,437 | – | – | 82,502 |
| Ellen Beausang Director | Jun 4, 2025 | Option exercise | +4,843 | – | – | 6,458 |
| Jeffrey k. cohen Director | May 13, 2025 | Award | +11,653 | $0.07 | $816 | 60,913 |
| Jeffrey k. cohen Director | May 9, 2025 | Award | +44,260 | $0.07 | $3.10K | 49,260 |
| Ellen O'Connor Vos Director | Mar 31, 2025 | Option exercise | +5,313 | – | – | 68,677 |
| Celeste Rachelle Fralick Director | Mar 31, 2025 | Option exercise | +5,000 | – | – | 55,665 |
| John Phillip Ragard Director | Mar 31, 2025 | Option exercise | +4,843 | – | – | 129,890 |
| Ellen Beausang Director | Mar 31, 2025 | Option exercise | +1,615 | – | – | 1,615 |
| Stefanie L. Cavanaugh Director | Mar 31, 2025 | Option exercise | +5,938 | – | – | 72,789 |
| Jannie Prestridge Herchuk Director | Mar 31, 2025 | Option exercise | +8,438 | – | – | 74,065 |
| Winfred Parnell Director | Mar 31, 2025 | Option exercise | +5,156 | – | – | 66,053 |
| Sandra Milligan Interim CEO | Jan 8, 2025 | Tax withholding | −6,356 | $0.70 | $4.45K | 13,644 |
| Sandra Milligan Interim CEO | Dec 31, 2024 | Option exercise | +20,000 | – | – | 20,000 |
| Stefanie L. Cavanaugh Director | Dec 31, 2024 | Option exercise | +5,937 | – | – | 66,851 |
| Sandra Milligan Interim CEO & President | Dec 31, 2024 | Option exercise | +20,000 | – | – | 20,000 |
| John Phillip Ragard Director | Dec 31, 2024 | Option exercise | +4,844 | – | – | 125,047 |
| Ellen O'Connor Vos Director | Dec 31, 2024 | Option exercise | +5,312 | – | – | 63,364 |
| Jannie Prestridge Herchuk Director | Dec 31, 2024 | Option exercise | +8,437 | – | – | 65,627 |
| Winfred Parnell Director | Dec 31, 2024 | Option exercise | +5,157 | – | – | 60,897 |
| Celeste Rachelle Fralick Director | Dec 31, 2024 | Option exercise | +5,000 | – | – | 50,665 |
| John Phillip Ragard Director | Sep 30, 2024 | Option exercise | +4,844 | – | – | 120,203 |
| Ellen O'Connor Vos Director | Sep 30, 2024 | Option exercise | +5,313 | – | – | 58,052 |
| Jannie Prestridge Herchuk Director | Sep 30, 2024 | Option exercise | +8,438 | – | – | 57,190 |
| Celeste Rachelle Fralick Director | Sep 30, 2024 | Option exercise | +5,000 | – | – | 45,665 |
| John Phillip Ragard Director | Sep 30, 2024 | Option exercise | +4,844 | – | – | 120,203 |
| Stefanie L. Cavanaugh Director | Sep 30, 2024 | Option exercise | +5,938 | – | – | 60,914 |
| Winfred Parnell Director | Sep 30, 2024 | Option exercise | +5,156 | – | – | 55,740 |
| Ellen O'Connor Vos Director | Aug 12, 2024 | Award | +16,593 | – | – | 52,739 |
| Winfred Parnell Director | Aug 12, 2024 | Award | +15,803 | – | – | 50,584 |
| Celeste Rachelle Fralick Director | Aug 12, 2024 | Award | +15,381 | – | – | 40,665 |
| Stefanie L. Cavanaugh Director | Aug 12, 2024 | Award | +16,804 | – | – | 54,976 |
| Jannie Prestridge Herchuk Director | Aug 12, 2024 | Award | +20,017 | – | – | 48,752 |
| Jack W. Schuler 10% owner | Jul 9, 2024 | Buy | +6,536 | – | – | 6,536 |
| Jannie Prestridge Herchuk Director | Jul 9, 2024 | Award | +4,902 | – | – | 28,735 |
| Ellen O'Connor Vos Director | Jul 9, 2024 | Award | +3,268 | – | – | 36,146 |
| Winfred Parnell Director | Jul 9, 2024 | Award | +3,268 | – | – | 34,781 |
| Stefanie L. Cavanaugh Director | Jul 9, 2024 | Award | +3,268 | – | – | 38,172 |
| Nicole Sandford CEO, Director | Jul 9, 2024 | Award | +13,072 | – | – | 83,668 |
| Nicole Sandford Chief Executive Officer, Director | May 31, 2024 | Buy | +9,493 | $2.42 | $22.97K | 70,596 |
| Jack W. Schuler 10% owner | Jan 26, 2024 | Buy | +28,500 | – | – | 1,912,156 |
| Nicole Sandford President & CEO, Director | Jan 26, 2024 | Buy | +2,400 | – | – | 61,103 |
| Minh Hoang Merchant Secretary & General Counsel | Dec 6, 2023 | Sale | −980 | $3.37 | $3.30K | 0 |
| Nicole Sandford President & CEO, Director | Dec 6, 2023 | Buy | +5,000 | $3.36 | $16.80K | 58,703 |
| Minh Hoang Merchant Secretary & General Counsel | Nov 17, 2023 | Award | +10,000 | – | – | 26,865 |
| Torsten Hombeck Chief Financial Officer | Nov 17, 2023 | Award | +30,000 | – | – | 33,000 |
| Torsten Hombeck Chief Financial Officer | Sep 8, 2023 | Buy | +2,246 | $4.30 | $9.66K | 3,000 |
| Nicole Sandford President & CEO, Director | Aug 29, 2023 | Award | +26,467 | – | – | 53,703 |
| Nicole Sandford President and CEO, Director | Aug 29, 2023 | Award | +26,367 | – | – | 187,499 |
| Celeste Rachelle Fralick Director | Aug 28, 2023 | Award | +13,252 | – | – | 25,284 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Aspira Women's Health's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?